The global sodium iodide market size will reach a valuation of USD 173 million in 2024, attributed to factors such as shift ...

Germany’s Merck KGaA has signed a collaboration with Tencent to develop digital healthcare services in China. Darmstadt-based Merck’s strategic tie-up with the China-based multinational tech ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck KGaA’s ATR inhibitor cancer drug has been cleared for further clinical trials after it showed encouraging activity in a phase 1 study. Short for ataxia telangiectasia and Rad3-related ...

Guggenheim analyst Vamil Divan maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best large-cap value stocks to buy as the recession hits. Goldman Sachs highlighted that ...

In a report released on April 16, Thomas Besson from Kepler Capital maintained a Sell rating on Hella KGaA Hueck & Co (0R3U – Research Report), with a price target of €60.00. The company’s ...

The global peptone market is experiencing steady growth, driven by its critical role in microbiological applications, ...

Analysts' ratings for Merck & Co MRK over the last quarter vary from bullish to bearish, as provided by 9 analysts. The table below provides a snapshot of their recent ratings, showcasing how ...

Merck MRK is a healthcare company that manufactures pharmaceutical products to treat various conditions in many therapeutic areas, including cardiometabolic disease, cancer and infections ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other value stocks in Ken Fisher’s portfolio. Trump’s “stupid” tariffs will fail ...